MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Stiff person syndrome: about a Tunisian case series

    YO. Memmich, RA. Zouari, ZA. Saied, AM. Rachdi, DI. Ben Mohamed, SAM. Ben Sassi (Tunis, Tunisia)

    Objective: The aim of this study is to describe a Tunisian case series of patients with SPS and to determinate its particularity compared to other…
  • 2025 International Congress

    Perinatal Dioxin Exposure and Dopaminergic Vulnerability in the Development of Motor Dysfunction Sequelae

    N. Choudhury, S. Shugar, B. Carr (Gainesville, USA)

    Objective: To investigate the impact of dioxins on movement disorder development and the mechanisms increasing vulnerability to future motor dysfunction. Background: Dioxins are persistent organic…
  • 2025 International Congress

    IPX203 (ER CD-LD) super-responders: Description of a patient subpopulation reaping extra benefits in dose-response when converting from IR CD-LD

    S. Allard, G. Banisadr, S. Fisher, P. Lewitt (Bridgewater, USA)

    Objective: To generate quantitative data helping dose optimization when converting Parkinson’s disease (PD) patients from IR CD-LD to IPX203. Background: IPX203 is the first extended-release…
  • 2025 International Congress

    Theta burst transcranial ultrasound stimulation of internal globus pallidus and motor cortex in Parkinson’s disease

    YY. Lin, N. Raies, T. Grippe, A. Bhattacharya, C. Sarica, G. Darmani, R. Chen (Taoyuan City, Taiwan)

    Objective: To compared the effects of theta burst transcranial ultrasound stimulation (tbTUS) applied to M1, the GPi, and simultaneous M1 and GPi stimulation to investigate…
  • 2025 International Congress

    Retro walking: A Potential Indicator of Physical Frailty in Parkinson’s Disease.

    M. van Emde-Boas, C. Stonsaovapak, N. Bohnen, C. Pongmala (Ann Arbor, USA)

    Objective: To examine the associations between retro walking and frailty parameters such as low grip strength, exhaustion, low physical activity and weight loss and compare…
  • 2025 International Congress

    Investigation of cortex – basal ganglia pathways with cortical stimulation and subthalamic evoked responses in patients with Parkinson’s disease

    J-C. Beyer, A. Cavallo, R M. Köhler, J. Vanhoecke, G-H. Schneider, A A. Kühn, W-J. Neumann (Berlin, Germany)

    Objective: To investigate the electrophysiological interplay between the human cortex and the subthalamic nucleus (STN) by comparing STN responses to direct cortical electrical stimulation and…
  • 2025 International Congress

    Diagnostic Work Up when Suspecting Early Onset Parkinson Disease (EOPD) Recommendations from the MDS EOPD Study Group

    R. Mehanna, C. Marras, J. Fleisher, B. Post, K. Kumar, A. Noyce, R. Alcalay, H. Morris, T. Hatano, M. Salari, K. Smilowska, Y. Wu, B. Zhang, E. Tan, R. Savica (Houston, USA)

    Objective: Objective: To establish recommendations regarding which investigations are needed for the diagnosis of Early onset Parkinson’s disease (EOPD) Background: Background: EOPD has been defined…
  • 2025 International Congress

    Advancing the Quality of Life of Parkinson’s Disease (PD) Patients in Ethiopia: The Impact of Self-Management and Coping Skills Training Programs on Patients in a Resource Constrained Settings

    T. Yinesu, Z. Bayu (Addis Ababa, Ethiopia)

    Objective: Evaluating the effectiveness of training in self-management and coping skills for patients with PD Background: The Parkinson’s Patients Support Organization Ethiopia (PPSO-E) implemented a…
  • 2025 International Congress

    G-Can, the GBA1 Canada Initiative

    L. Chebon, P. Halder, E. Fon, T. Durcan, M. Parent, N. Dupre, M. Sharp, R. Postuma, G. Armstrong, A. Milnerwood, A. Dagher, J. Raamsdonk, J. Trempe, T. Goldsmith, X. Chen, N. Aprahamian, Z. You, M. Nicoleau, E. Deneault, A. Bayne, C. Laflamme, P. Mcpherson, M. Pandolfo, G. Rouleau, Z. Gan-Or (Québec, Canada)

    Objective: G-Can, the GBA1 Canada Initiative, is an open-science platform which aims to advance GBA1 research and develop treatments for GBA1 mutation-related Parkinson's disease (PD).…
  • 2025 International Congress

    Screening for Neuronal Synuclein Disease (NSD) using cerebrospinal fluid (CSF) in the Parkinson Progression Marker Initiative (PPMI)

    J. Dimos, B. Mcmahon, L. Lemon, A. Siderowf, T. Simuni, C. Tanner, K. Marek, C. Coffey, T. Foroud, L. Chahine, E. Brown, T. Tropea, M. Kuhl, A. Bright, M. Totten, G. Antonopoulos, L. Heathers (New Haven, USA)

    Objective: To utilize a centralized screening paradigm for early stage NSD based on sequential olfactory dysfunction (measured by University of Pennsylvania Smell Identification test (UPSIT))…
  • « Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley